Understanding Hermansky-Pudlak Syndrome
Hermansky-Pudlak Syndrome is a rare inherited disorder causing oculocutaneous albinism, a bleeding tendency from platelet storage pool deficiency, and in some subtypes, progressive lung and bowel disease.
- Autosomal recessive inheritance
- Albinism with bleeding tendency
- Multisystem monitoring needed
- Most Common In
- Both sexes (autosomal recessive)
- Causative Genes
- HPS1–HPS11
- Key Feature
- Albinism + platelet storage pool deficiency
- Advanced Therapies
- Antifibrotic agents, lung transplant evaluation
Condition Overview
Hermansky-Pudlak Syndrome (HPS) is a rare autosomal recessive disorder caused by mutations in one of several genes (HPS1 through HPS11) involved in forming specialized cellular structures called lysosome-related organelles. This leads to oculocutaneous albinism (reduced pigmentation of skin, hair, and eyes), a bleeding tendency due to platelet storage pool deficiency, and in some subtypes, progressive pulmonary fibrosis or granulomatous colitis.
Types and Subtypes
HPS is classified by the specific causative gene, which influences the pattern and severity of associated complications.
Symptoms and Signs
Symptoms span pigmentation, bleeding, vision, and in some subtypes, lung and bowel involvement.
Causes and Risk Factors
HPS is caused by inherited mutations affecting genes responsible for building specialized intracellular compartments.
Diagnosis and Investigations
Diagnosis combines clinical features of albinism and bleeding with specialized platelet and genetic testing.
Risk Stratification
Risk in HPS is best framed by subtype and degree of organ involvement rather than a traditional staging system.
Standard Treatment
Management is multidisciplinary, addressing bleeding risk, vision, and monitoring for pulmonary or bowel complications.
Advanced & Emerging Therapies
Management of pulmonary fibrosis in HPS increasingly draws on therapies developed for other fibrotic lung diseases.
Antifibrotic Therapy
Pirfenidone and similar antifibrotic agents
Studied to slow progression of pulmonary fibrosis in HPS-1 and HPS-4.
Lung Transplantation
Lung transplant evaluation
Considered for patients with advanced HPS-related pulmonary fibrosis.
Precision Genetic Counseling
Subtype-specific genetic confirmation
Helps tailor monitoring intensity based on the specific HPS gene involved.
Biomarkers & Monitoring
Genetic and functional testing help confirm diagnosis, subtype, and guide monitoring intensity.
When to Seek a Second Opinion
A second opinion is especially valuable for confirming subtype and planning long-term multisystem monitoring.
Clinical Trials & Research
Prognosis & Outcomes
Prognosis varies significantly by subtype: bleeding-related issues are generally manageable, but pulmonary fibrosis in HPS-1 and HPS-4 can be progressive and life-limiting.
Supportive Care
Supportive care addresses the multisystem nature of HPS, from skin protection to respiratory support.
How CancerFax Helps You Explore Treatment Options
CancerFax helps patients and families with Hermansky-Pudlak Syndrome access specialist review, coordinate multidisciplinary care across hematology and pulmonology, and explore options including antifibrotic therapy and transplant evaluation.
Get a free case reviewFrequently Asked Questions
It is a rare inherited disorder causing albinism, a bleeding tendency due to platelet storage pool deficiency, and in some subtypes, progressive lung or bowel disease.
It is caused by mutations in one of several genes (HPS1–HPS11) needed to build specialized structures inside cells.
No, severity and organ involvement vary by genetic subtype, with HPS-1 and HPS-4 carrying the highest risk of pulmonary fibrosis.
Diagnosis combines clinical features of albinism and bleeding with platelet electron microscopy and genetic testing.
In certain subtypes, particularly HPS-1 and HPS-4, patients can develop progressive pulmonary fibrosis, usually beginning in adulthood.
Some patients develop granulomatous colitis, a condition resembling inflammatory bowel disease.
There is no cure, but bleeding risk, vision, and lung or bowel complications can be actively managed with specialist care.
Antifibrotic medications and, in advanced cases, lung transplant evaluation are options being used and studied.
Yes, since it is an inherited recessive condition, genetic counseling can help families understand risk for future pregnancies.
Yes. CancerFax assists with medical report review, second opinion coordination, and connecting patients with specialist centers for multidisciplinary HPS care, including international coordination where relevant.
Get Expert Guidance on Hermansky-Pudlak Syndrome
Send your medical reports for a specialist review and coordinate multidisciplinary care for HPS.